Elanco (NYSE: ELAN) director receives deferred and restricted stock units
Rhea-AI Filing Summary
Kurzius Lawrence Erik reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc director Lawrence Erik Kurzius reported two equity awards of common stock on May 21, 2026. He received 12,196 deferred stock units as a pro-rated annual equity award and 4,678 restricted stock units as an annual equity grant for non-employee directors.
Both awards were recorded at $0.00 per share, reflecting compensation grants rather than open-market purchases.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 16,874 shares
Net Buy
2 txns
Insider
Kurzius Lawrence Erik
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,678 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 12,196 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 148,647 shares (Direct)
Footnotes (2)
- F1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
- F2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Key Figures
Deferred stock units granted: 12,196 units
Restricted stock units granted: 4,678 units
Transaction code: A (Grant, award, or other acquisition)
+1 more
4 metrics
Deferred stock units granted
12,196 units
Pro-rated annual equity award on May 21, 2026
Restricted stock units granted
4,678 units
Annual equity award on May 21, 2026
Transaction code
A (Grant, award, or other acquisition)
Both non-derivative transactions on May 21, 2026
Reported price per share
$0.00 per share
For both equity grants reported in the Form 4
Key Terms
deferred stock units, restricted stock units, annual equity award, non-employee members of the Issuer's Board of Directors
4 terms
deferred stock units financial
"Grant of deferred stock units as a pro-rated annual equity award"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
restricted stock units financial
"Grant of restricted stock units as an annual equity award"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
annual equity award financial
"as a pro-rated annual equity award to each of the non-employee members"
non-employee members of the Issuer's Board of Directors financial
"to each of the non-employee members of the Issuer's Board of Directors"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Elanco (ELAN) director Lawrence Erik Kurzius report in this Form 4?
He reported receiving two equity awards of Elanco common stock as board compensation. The filing shows grants of deferred stock units and restricted stock units, rather than any open-market purchases or sales of shares.
How many Elanco (ELAN) deferred stock units were granted to director Kurzius?
He received 12,196 deferred stock units as a pro-rated annual equity award. These units are compensation for serving as a non-employee member of Elanco’s Board of Directors, not shares bought in the open market.
How many restricted stock units did Elanco (ELAN) grant to Kurzius?
He was granted 4,678 restricted stock units as an annual equity award. These RSUs are part of Elanco’s compensation program for non-employee directors and were recorded at a price of $0.00 per share in the Form 4.
Were Kurzius’s Elanco (ELAN) Form 4 transactions open-market trades?
No, the transactions reflect compensation-related equity grants, not market trades. Both entries use transaction code A, described as a grant, award or other acquisition, and are tied to the company’s non-employee director equity program.
What do the footnotes in the Elanco (ELAN) Form 4 say about these grants?
The footnotes explain that 12,196 units are deferred stock units and 4,678 are restricted stock units. Both are annual equity awards granted to each non-employee member of Elanco’s Board of Directors as part of their regular compensation.